Standard BioTools Inc. (NASDAQ: FLDM) Stock Competitors & Peer Comparison
See FLDM's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for FLDM and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FLDM | $3.71 | -7.02% | 294.2M | -4.74 | -$0.78 | N/A |
| DHR-PB | $1,261.26 | -0.78% | 916.8B | 146.01 | $8.64 | +0.70% |
| TMO | $656.58 | -2.98% | 242.8B | 28.35 | $23.16 | +0.28% |
| DHR | $215.61 | -2.53% | 151.5B | 27.01 | $7.98 | +0.70% |
| NTRA | $400.65 | -5.87% | 57.4B | -303.52 | -$1.32 | N/A |
| A | $169.33 | -1.14% | 47.8B | 29.15 | $5.81 | +0.60% |
| WAT | $436.43 | -0.84% | 42.9B | 31.90 | $13.68 | N/A |
| IQV | $259.98 | -2.30% | 42.8B | 21.45 | $12.13 | N/A |
| ILMN | $273.54 | -6.86% | 41.4B | 54.38 | $5.03 | N/A |
| IDXX | $515.41 | -2.21% | 40.7B | 36.25 | $14.22 | N/A |
Stock Comparison
Danaher Corporation (NYSE: DHR-PB)
FLDM vs DHR-PB Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while DHR-PB trades at $1,261.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, FLDM's ROE is +0.18%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, FLDM is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check DHR-PB's competition here
Thermo Fisher Scientific Inc. (NYSE: TMO)
FLDM vs TMO Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, TMO has a market cap of 242.8B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while TMO trades at $656.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas TMO's P/E ratio is 28.35. In terms of profitability, FLDM's ROE is +0.18%, compared to TMO's ROE of +0.13%. Regarding short-term risk, FLDM is more volatile compared to TMO. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check TMO's competition here
Danaher Corporation (NYSE: DHR)
FLDM vs DHR Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DHR has a market cap of 151.5B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while DHR trades at $215.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DHR's P/E ratio is 27.01. In terms of profitability, FLDM's ROE is +0.18%, compared to DHR's ROE of +0.08%. Regarding short-term risk, FLDM is more volatile compared to DHR. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check DHR's competition here
Natera, Inc. (NASDAQ: NTRA)
FLDM vs NTRA Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NTRA has a market cap of 57.4B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while NTRA trades at $400.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NTRA's P/E ratio is -303.52. In terms of profitability, FLDM's ROE is +0.18%, compared to NTRA's ROE of -0.12%. Regarding short-term risk, FLDM is less volatile compared to NTRA. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check NTRA's competition here
Agilent Technologies, Inc. (NYSE: A)
FLDM vs A Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, A has a market cap of 47.8B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while A trades at $169.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas A's P/E ratio is 29.15. In terms of profitability, FLDM's ROE is +0.18%, compared to A's ROE of +0.20%. Regarding short-term risk, FLDM is more volatile compared to A. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check A's competition here
Waters Corporation (NYSE: WAT)
FLDM vs WAT Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, WAT has a market cap of 42.9B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while WAT trades at $436.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas WAT's P/E ratio is 31.90. In terms of profitability, FLDM's ROE is +0.18%, compared to WAT's ROE of +0.02%. Regarding short-term risk, FLDM is more volatile compared to WAT. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check WAT's competition here
IQVIA Holdings Inc. (NYSE: IQV)
FLDM vs IQV Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, IQV has a market cap of 42.8B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while IQV trades at $259.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas IQV's P/E ratio is 21.45. In terms of profitability, FLDM's ROE is +0.18%, compared to IQV's ROE of +0.22%. Regarding short-term risk, FLDM is more volatile compared to IQV. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check IQV's competition here
Illumina, Inc. (NASDAQ: ILMN)
FLDM vs ILMN Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ILMN has a market cap of 41.4B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ILMN trades at $273.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ILMN's P/E ratio is 54.38. In terms of profitability, FLDM's ROE is +0.18%, compared to ILMN's ROE of +0.31%. Regarding short-term risk, FLDM is less volatile compared to ILMN. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check ILMN's competition here
IDEXX Laboratories, Inc. (NASDAQ: IDXX)
FLDM vs IDXX Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, IDXX has a market cap of 40.7B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while IDXX trades at $515.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas IDXX's P/E ratio is 36.25. In terms of profitability, FLDM's ROE is +0.18%, compared to IDXX's ROE of +0.72%. Regarding short-term risk, FLDM is more volatile compared to IDXX. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check IDXX's competition here
Mettler-Toledo International Inc. (NYSE: MTD)
FLDM vs MTD Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MTD has a market cap of 31B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while MTD trades at $1,533.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MTD's P/E ratio is 35.21. In terms of profitability, FLDM's ROE is +0.18%, compared to MTD's ROE of -12.00%. Regarding short-term risk, FLDM is more volatile compared to MTD. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check MTD's competition here
Labcorp Holdings Inc. (NYSE: LH)
FLDM vs LH Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, LH has a market cap of 25.6B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while LH trades at $311.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas LH's P/E ratio is 18.50. In terms of profitability, FLDM's ROE is +0.18%, compared to LH's ROE of +0.12%. Regarding short-term risk, FLDM is more volatile compared to LH. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check LH's competition here
Quest Diagnostics Incorporated (NYSE: DGX)
FLDM vs DGX Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DGX has a market cap of 25.2B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while DGX trades at $228.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DGX's P/E ratio is 22.53. In terms of profitability, FLDM's ROE is +0.18%, compared to DGX's ROE of +0.14%. Regarding short-term risk, FLDM is more volatile compared to DGX. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check DGX's competition here
Guardant Health, Inc. (NASDAQ: GH)
FLDM vs GH Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GH has a market cap of 22.9B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while GH trades at $170.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GH's P/E ratio is -48.91. In terms of profitability, FLDM's ROE is +0.18%, compared to GH's ROE of +2.11%. Regarding short-term risk, FLDM is less volatile compared to GH. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check GH's competition here
Exact Sciences Corporation (NASDAQ: EXAS)
FLDM vs EXAS Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, EXAS has a market cap of 20B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while EXAS trades at $104.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas EXAS's P/E ratio is -95.37. In terms of profitability, FLDM's ROE is +0.18%, compared to EXAS's ROE of -0.04%. Regarding short-term risk, FLDM is more volatile compared to EXAS. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check EXAS's competition here
Revvity, Inc. (NYSE: RVTY)
FLDM vs RVTY Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, RVTY has a market cap of 17.1B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while RVTY trades at $153.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas RVTY's P/E ratio is 28.66. In terms of profitability, FLDM's ROE is +0.18%, compared to RVTY's ROE of +0.03%. Regarding short-term risk, FLDM is less volatile compared to RVTY. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check RVTY's competition here
Illumina, Inc. Common Stock Ex-distribution When-Issued (NASDAQ: ILMNV)
FLDM vs ILMNV Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ILMNV has a market cap of 17B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ILMNV trades at $107.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ILMNV's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to ILMNV's ROE of N/A. Regarding short-term risk, FLDM is more volatile compared to ILMNV. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check ILMNV's competition here
Medpace Holdings, Inc. (NASDAQ: MEDP)
FLDM vs MEDP Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MEDP has a market cap of 16.8B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while MEDP trades at $602.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MEDP's P/E ratio is 35.34. In terms of profitability, FLDM's ROE is +0.18%, compared to MEDP's ROE of +1.10%. Regarding short-term risk, FLDM is more volatile compared to MEDP. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check MEDP's competition here
Charles River Laboratories International, Inc. (NYSE: CRL)
FLDM vs CRL Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CRL has a market cap of 14.7B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CRL trades at $304.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CRL's P/E ratio is 30.81. In terms of profitability, FLDM's ROE is +0.18%, compared to CRL's ROE of -0.08%. Regarding short-term risk, FLDM is less volatile compared to CRL. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check CRL's competition here
PerkinElmer, Inc. (NYSE: PKI)
FLDM vs PKI Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PKI has a market cap of 14.5B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while PKI trades at $115.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PKI's P/E ratio is 41.45. In terms of profitability, FLDM's ROE is +0.18%, compared to PKI's ROE of +0.03%. Regarding short-term risk, FLDM is more volatile compared to PKI. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check PKI's competition here
ICON Public Limited Company (NASDAQ: ICLR)
FLDM vs ICLR Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ICLR has a market cap of 12.4B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ICLR trades at $161.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ICLR's P/E ratio is 13.19. In terms of profitability, FLDM's ROE is +0.18%, compared to ICLR's ROE of +0.04%. Regarding short-term risk, FLDM is less volatile compared to ICLR. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check ICLR's competition here
Qiagen N.V. (NYSE: QGEN)
FLDM vs QGEN Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, QGEN has a market cap of 9.4B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while QGEN trades at $45.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas QGEN's P/E ratio is 18.87. In terms of profitability, FLDM's ROE is +0.18%, compared to QGEN's ROE of +0.12%. Regarding short-term risk, FLDM is more volatile compared to QGEN. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check QGEN's competition here
GRAIL Inc. (NASDAQ: GRAL)
FLDM vs GRAL Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GRAL has a market cap of 5.9B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while GRAL trades at $137.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GRAL's P/E ratio is -14.08. In terms of profitability, FLDM's ROE is +0.18%, compared to GRAL's ROE of -0.16%. Regarding short-term risk, FLDM is less volatile compared to GRAL. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check GRAL's competition here
RadNet, Inc. (NASDAQ: RDNT)
FLDM vs RDNT Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, RDNT has a market cap of 5.5B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while RDNT trades at $70.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas RDNT's P/E ratio is 152.78. In terms of profitability, FLDM's ROE is +0.18%, compared to RDNT's ROE of -0.02%. Regarding short-term risk, FLDM is more volatile compared to RDNT. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check RDNT's competition here
Sotera Health Company (NASDAQ: SHC)
FLDM vs SHC Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SHC has a market cap of 5.2B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while SHC trades at $18.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SHC's P/E ratio is 19.01. In terms of profitability, FLDM's ROE is +0.18%, compared to SHC's ROE of +0.27%. Regarding short-term risk, FLDM is more volatile compared to SHC. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check SHC's competition here
BillionToOne, Inc. (NASDAQ: BLLN)
FLDM vs BLLN Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BLLN has a market cap of 4.6B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BLLN trades at $99.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BLLN's P/E ratio is 142.72. In terms of profitability, FLDM's ROE is +0.18%, compared to BLLN's ROE of +0.08%. Regarding short-term risk, FLDM is less volatile compared to BLLN. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check BLLN's competition here
Syneos Health, Inc. (NASDAQ: SYNH)
FLDM vs SYNH Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SYNH has a market cap of 4.5B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while SYNH trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SYNH's P/E ratio is 61.40. In terms of profitability, FLDM's ROE is +0.18%, compared to SYNH's ROE of +0.08%. Regarding short-term risk, FLDM is more volatile compared to SYNH. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check SYNH's competition here
Veracyte, Inc. (NASDAQ: VCYT)
FLDM vs VCYT Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, VCYT has a market cap of 3.6B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while VCYT trades at $44.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas VCYT's P/E ratio is 22.33. In terms of profitability, FLDM's ROE is +0.18%, compared to VCYT's ROE of +0.09%. Regarding short-term risk, FLDM is less volatile compared to VCYT. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check VCYT's competition here
CareDx, Inc (NASDAQ: CDNA)
FLDM vs CDNA Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CDNA has a market cap of 3.3B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CDNA trades at $63.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CDNA's P/E ratio is 75.94. In terms of profitability, FLDM's ROE is +0.18%, compared to CDNA's ROE of +0.33%. Regarding short-term risk, FLDM is less volatile compared to CDNA. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check CDNA's competition here
Olink Holding AB (publ) (NASDAQ: OLK)
FLDM vs OLK Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OLK has a market cap of 3.2B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while OLK trades at $26.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OLK's P/E ratio is -96.59. In terms of profitability, FLDM's ROE is +0.18%, compared to OLK's ROE of -0.07%. Regarding short-term risk, FLDM is more volatile compared to OLK. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check OLK's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
FLDM vs WGS Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, WGS has a market cap of 2.1B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while WGS trades at $71.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas WGS's P/E ratio is 198.67. In terms of profitability, FLDM's ROE is +0.18%, compared to WGS's ROE of -0.39%. Regarding short-term risk, FLDM is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check WGS's competition here
Personalis, Inc. (NASDAQ: PSNL)
FLDM vs PSNL Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PSNL has a market cap of 1.7B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while PSNL trades at $16.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PSNL's P/E ratio is -14.71. In terms of profitability, FLDM's ROE is +0.18%, compared to PSNL's ROE of -0.46%. Regarding short-term risk, FLDM is more volatile compared to PSNL. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check PSNL's competition here
OPKO Health, Inc. (NASDAQ: OPK)
FLDM vs OPK Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OPK has a market cap of 1.1B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while OPK trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OPK's P/E ratio is -16.22. In terms of profitability, FLDM's ROE is +0.18%, compared to OPK's ROE of -0.06%. Regarding short-term risk, FLDM is more volatile compared to OPK. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check OPK's competition here
Castle Biosciences, Inc. (NASDAQ: CSTL)
FLDM vs CSTL Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CSTL has a market cap of 1B. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CSTL trades at $33.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CSTL's P/E ratio is -50.55. In terms of profitability, FLDM's ROE is +0.18%, compared to CSTL's ROE of -0.04%. Regarding short-term risk, FLDM is less volatile compared to CSTL. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check CSTL's competition here
Fulgent Genetics, Inc. (NASDAQ: FLGT)
FLDM vs FLGT Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, FLGT has a market cap of 584.5M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while FLGT trades at $20.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas FLGT's P/E ratio is 2058.00. In terms of profitability, FLDM's ROE is +0.18%, compared to FLGT's ROE of -0.08%. Regarding short-term risk, FLDM is less volatile compared to FLGT. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check FLGT's competition here
GRAIL, Inc. Common Stock (NASDAQ: GRALV)
FLDM vs GRALV Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GRALV has a market cap of 579.4M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while GRALV trades at $18.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GRALV's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to GRALV's ROE of N/A. Regarding short-term risk, FLDM is more volatile compared to GRALV. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check GRALV's competition here
NeoGenomics, Inc. (NASDAQ: NEO)
FLDM vs NEO Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NEO has a market cap of 424.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while NEO trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NEO's P/E ratio is 126.96. In terms of profitability, FLDM's ROE is +0.18%, compared to NEO's ROE of -0.06%. Regarding short-term risk, FLDM is less volatile compared to NEO. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check NEO's competition here
Myriad Genetics, Inc. (NASDAQ: MYGN)
FLDM vs MYGN Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MYGN has a market cap of 404.2M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while MYGN trades at $4.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MYGN's P/E ratio is -32.92. In terms of profitability, FLDM's ROE is +0.18%, compared to MYGN's ROE of -0.33%. Regarding short-term risk, FLDM is less volatile compared to MYGN. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check MYGN's competition here
Global Cord Blood Corporation (NYSE: CO)
FLDM vs CO Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CO has a market cap of 400.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CO trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CO's P/E ratio is 5.06. In terms of profitability, FLDM's ROE is +0.18%, compared to CO's ROE of +0.11%. Regarding short-term risk, FLDM is less volatile compared to CO. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check CO's competition here
Biodesix, Inc. (NASDAQ: BDSX)
FLDM vs BDSX Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BDSX has a market cap of 227.6M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BDSX trades at $27.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BDSX's P/E ratio is -8.82. In terms of profitability, FLDM's ROE is +0.18%, compared to BDSX's ROE of -7.88%. Regarding short-term risk, FLDM is more volatile compared to BDSX. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check BDSX's competition here
Exagen Inc. (NASDAQ: XGN)
FLDM vs XGN Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, XGN has a market cap of 197.9M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while XGN trades at $8.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas XGN's P/E ratio is -10.11. In terms of profitability, FLDM's ROE is +0.18%, compared to XGN's ROE of -1.22%. Regarding short-term risk, FLDM is more volatile compared to XGN. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check XGN's competition here
Freenome, Inc. (NASDAQ: FRNM)
FLDM vs FRNM Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, FRNM has a market cap of 133.5M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while FRNM trades at $16.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas FRNM's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to FRNM's ROE of N/A. Regarding short-term risk, FLDM is more volatile compared to FRNM. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check FRNM's competition here
Genetron Holdings Limited (NASDAQ: GTH)
FLDM vs GTH Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GTH has a market cap of 127.3M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while GTH trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GTH's P/E ratio is -1.11. In terms of profitability, FLDM's ROE is +0.18%, compared to GTH's ROE of -1.01%. Regarding short-term risk, FLDM is more volatile compared to GTH. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check GTH's competition here
Genetic Technologies Limited (NASDAQ: GENE)
FLDM vs GENE Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, GENE has a market cap of 111.2M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while GENE trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas GENE's P/E ratio is -38.25. In terms of profitability, FLDM's ROE is +0.18%, compared to GENE's ROE of -1.85%. Regarding short-term risk, FLDM is more volatile compared to GENE. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check GENE's competition here
Insight Molecular Diagnostics Inc. (NASDAQ: IMDX)
FLDM vs IMDX Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, IMDX has a market cap of 109.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while IMDX trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas IMDX's P/E ratio is -2.27. In terms of profitability, FLDM's ROE is +0.18%, compared to IMDX's ROE of +2.72%. Regarding short-term risk, FLDM is less volatile compared to IMDX. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check IMDX's competition here
Sera Prognostics, Inc. (NASDAQ: SERA)
FLDM vs SERA Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SERA has a market cap of 78.3M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while SERA trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SERA's P/E ratio is -3.15. In terms of profitability, FLDM's ROE is +0.18%, compared to SERA's ROE of -0.47%. Regarding short-term risk, FLDM is more volatile compared to SERA. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check SERA's competition here
Precipio, Inc. (NASDAQ: PRPO)
FLDM vs PRPO Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PRPO has a market cap of 41.8M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while PRPO trades at $23.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PRPO's P/E ratio is -36.08. In terms of profitability, FLDM's ROE is +0.18%, compared to PRPO's ROE of -0.08%. Regarding short-term risk, FLDM is more volatile compared to PRPO. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check PRPO's competition here
MDxHealth S.A. (NASDAQ: MDXH)
FLDM vs MDXH Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MDXH has a market cap of 30.8M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while MDXH trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MDXH's P/E ratio is -0.82. In terms of profitability, FLDM's ROE is +0.18%, compared to MDXH's ROE of +1.43%. Regarding short-term risk, FLDM is more volatile compared to MDXH. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check MDXH's competition here
Quantum Cyber N.V. (NASDAQ: QUCY)
FLDM vs QUCY Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, QUCY has a market cap of 29.4M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while QUCY trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas QUCY's P/E ratio is -0.06. In terms of profitability, FLDM's ROE is +0.18%, compared to QUCY's ROE of -3.65%. Regarding short-term risk, FLDM is more volatile compared to QUCY. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check QUCY's competition here
Akumin Inc. (NASDAQ: AKU)
FLDM vs AKU Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, AKU has a market cap of 26.3M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while AKU trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas AKU's P/E ratio is -0.13. In terms of profitability, FLDM's ROE is +0.18%, compared to AKU's ROE of -5.32%. Regarding short-term risk, FLDM is less volatile compared to AKU. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check AKU's competition here
Burning Rock Biotech Limited (NASDAQ: BNR)
FLDM vs BNR Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BNR has a market cap of 17.4M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BNR trades at $16.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BNR's P/E ratio is -18.97. In terms of profitability, FLDM's ROE is +0.18%, compared to BNR's ROE of -0.13%. Regarding short-term risk, FLDM is less volatile compared to BNR. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check BNR's competition here
Chembio Diagnostics, Inc. (NASDAQ: CEMI)
FLDM vs CEMI Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CEMI has a market cap of 16.7M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CEMI trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CEMI's P/E ratio is -0.63. In terms of profitability, FLDM's ROE is +0.18%, compared to CEMI's ROE of -0.89%. Regarding short-term risk, FLDM is more volatile compared to CEMI. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check CEMI's competition here
Enzo Biochem, Inc. (NYSE: ENZ)
FLDM vs ENZ Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ENZ has a market cap of 16.4M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ENZ trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ENZ's P/E ratio is -2.24. In terms of profitability, FLDM's ROE is +0.18%, compared to ENZ's ROE of -0.39%. Regarding short-term risk, FLDM is less volatile compared to ENZ. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check ENZ's competition here
Psychemedics Corporation (NASDAQ: PMD)
FLDM vs PMD Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PMD has a market cap of 15.6M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while PMD trades at $2.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PMD's P/E ratio is -5.24. In terms of profitability, FLDM's ROE is +0.18%, compared to PMD's ROE of -0.32%. Regarding short-term risk, FLDM is more volatile compared to PMD. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check PMD's competition here
23andMe Holding Co. (NASDAQ: ME)
FLDM vs ME Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ME has a market cap of 15.3M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ME trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ME's P/E ratio is -0.03. In terms of profitability, FLDM's ROE is +0.18%, compared to ME's ROE of -3.47%. Regarding short-term risk, FLDM is more volatile compared to ME. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check ME's competition here
Mainz Biomed B.V. (NASDAQ: MYNZ)
FLDM vs MYNZ Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MYNZ has a market cap of 14.7M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while MYNZ trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MYNZ's P/E ratio is -1.33. In terms of profitability, FLDM's ROE is +0.18%, compared to MYNZ's ROE of -1.80%. Regarding short-term risk, FLDM is less volatile compared to MYNZ. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check MYNZ's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAFW)
FLDM vs BIAFW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BIAFW has a market cap of 12.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BIAFW trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BIAFW's P/E ratio is 1.29. In terms of profitability, FLDM's ROE is +0.18%, compared to BIAFW's ROE of -2.57%. Regarding short-term risk, FLDM is more volatile compared to BIAFW. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check BIAFW's competition here
Check-Cap Ltd. (NASDAQ: CHEK)
FLDM vs CHEK Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CHEK has a market cap of 10.9M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CHEK trades at $1.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CHEK's P/E ratio is -0.43. In terms of profitability, FLDM's ROE is +0.18%, compared to CHEK's ROE of -2.26%. Regarding short-term risk, FLDM is more volatile compared to CHEK. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check CHEK's competition here
Centogene N.V. (NASDAQ: CNTG)
FLDM vs CNTG Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CNTG has a market cap of 9.4M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CNTG trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CNTG's P/E ratio is -0.23. In terms of profitability, FLDM's ROE is +0.18%, compared to CNTG's ROE of +3.98%. Regarding short-term risk, FLDM is more volatile compared to CNTG. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check CNTG's competition here
Advanced Biomed Inc. Common Stock (NASDAQ: ADVB)
FLDM vs ADVB Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ADVB has a market cap of 8.8M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ADVB trades at $6.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ADVB's P/E ratio is -58.00. In terms of profitability, FLDM's ROE is +0.18%, compared to ADVB's ROE of -0.21%. Regarding short-term risk, FLDM is more volatile compared to ADVB. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check ADVB's competition here
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
FLDM vs NDRA Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NDRA has a market cap of 7.7M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while NDRA trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NDRA's P/E ratio is -0.90. In terms of profitability, FLDM's ROE is +0.18%, compared to NDRA's ROE of -2.25%. Regarding short-term risk, FLDM is more volatile compared to NDRA. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check NDRA's competition here
Applied DNA Sciences, Inc. (NASDAQ: APDN)
FLDM vs APDN Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, APDN has a market cap of 7.3M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while APDN trades at $5.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas APDN's P/E ratio is -0.10. In terms of profitability, FLDM's ROE is +0.18%, compared to APDN's ROE of -7.23%. Regarding short-term risk, FLDM is less volatile compared to APDN. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check APDN's competition here
Invitae Corporation (NYSE: NVTA)
FLDM vs NVTA Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NVTA has a market cap of 5.4M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while NVTA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NVTA's P/E ratio is -0.00. In terms of profitability, FLDM's ROE is +0.18%, compared to NVTA's ROE of -2.02%. Regarding short-term risk, FLDM is less volatile compared to NVTA. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check NVTA's competition here
LumiraDx Limited (NASDAQ: LMDX)
FLDM vs LMDX Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, LMDX has a market cap of 5.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while LMDX trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas LMDX's P/E ratio is -0.01. In terms of profitability, FLDM's ROE is +0.18%, compared to LMDX's ROE of -15.58%. Regarding short-term risk, FLDM is less volatile compared to LMDX. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check LMDX's competition here
LumiraDx Limited (NASDAQ: LMDXW)
FLDM vs LMDXW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, LMDXW has a market cap of 5.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while LMDXW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas LMDXW's P/E ratio is -0.00. In terms of profitability, FLDM's ROE is +0.18%, compared to LMDXW's ROE of -15.58%. Regarding short-term risk, FLDM is less volatile compared to LMDXW. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check LMDXW's competition here
DermTech, Inc. (NASDAQ: DMTK)
FLDM vs DMTK Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DMTK has a market cap of 3.3M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while DMTK trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DMTK's P/E ratio is -0.04. In terms of profitability, FLDM's ROE is +0.18%, compared to DMTK's ROE of -1.06%. Regarding short-term risk, FLDM is less volatile compared to DMTK. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check DMTK's competition here
Inotiv, Inc. (NASDAQ: NOTV)
FLDM vs NOTV Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NOTV has a market cap of 2.8M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while NOTV trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NOTV's P/E ratio is -0.03. In terms of profitability, FLDM's ROE is +0.18%, compared to NOTV's ROE of -0.75%. Regarding short-term risk, FLDM is less volatile compared to NOTV. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check NOTV's competition here
iSpecimen Inc. (NASDAQ: ISPC)
FLDM vs ISPC Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, ISPC has a market cap of 2.7M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while ISPC trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas ISPC's P/E ratio is -0.03. In terms of profitability, FLDM's ROE is +0.18%, compared to ISPC's ROE of -5.24%. Regarding short-term risk, FLDM is more volatile compared to ISPC. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check ISPC's competition here
bioAffinity Technologies, Inc. (NASDAQ: BIAF)
FLDM vs BIAF Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BIAF has a market cap of 2.5M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BIAF trades at $6.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BIAF's P/E ratio is -0.71. In terms of profitability, FLDM's ROE is +0.18%, compared to BIAF's ROE of -2.57%. Regarding short-term risk, FLDM is less volatile compared to BIAF. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check BIAF's competition here
SeqLL Inc. (NASDAQ: SQL)
FLDM vs SQL Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SQL has a market cap of 2.5M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while SQL trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SQL's P/E ratio is -0.40. In terms of profitability, FLDM's ROE is +0.18%, compared to SQL's ROE of -30.46%. Regarding short-term risk, FLDM is less volatile compared to SQL. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check SQL's competition here
Aspira Women's Health Inc. (NASDAQ: AWH)
FLDM vs AWH Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, AWH has a market cap of 2.5M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while AWH trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas AWH's P/E ratio is -0.09. In terms of profitability, FLDM's ROE is +0.18%, compared to AWH's ROE of +1.62%. Regarding short-term risk, FLDM is more volatile compared to AWH. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check AWH's competition here
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM)
FLDM vs HTGM Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, HTGM has a market cap of 1.1M. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while HTGM trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas HTGM's P/E ratio is -0.03. In terms of profitability, FLDM's ROE is +0.18%, compared to HTGM's ROE of -2.73%. Regarding short-term risk, FLDM is more volatile compared to HTGM. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check HTGM's competition here
Biocept, Inc. (NASDAQ: BIOC)
FLDM vs BIOC Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BIOC has a market cap of 450.8K. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BIOC trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BIOC's P/E ratio is -0.01. In terms of profitability, FLDM's ROE is +0.18%, compared to BIOC's ROE of -1.38%. Regarding short-term risk, FLDM is less volatile compared to BIOC. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check BIOC's competition here
SeqLL Inc. (NASDAQ: SQLLW)
FLDM vs SQLLW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, SQLLW has a market cap of 179.6K. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while SQLLW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas SQLLW's P/E ratio is -0.00. In terms of profitability, FLDM's ROE is +0.18%, compared to SQLLW's ROE of -30.46%. Regarding short-term risk, FLDM is less volatile compared to SQLLW. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check SQLLW's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
FLDM vs WGSWW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, WGSWW has a market cap of 5.8K. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas WGSWW's P/E ratio is -0.00. In terms of profitability, FLDM's ROE is +0.18%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, FLDM is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check WGSWW's competition here
BioNano Genomics, Inc. WT EXP 082123 (NASDAQ: BNGOW)
FLDM vs BNGOW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, BNGOW has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while BNGOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas BNGOW's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to BNGOW's ROE of -0.79%. Regarding short-term risk, FLDM is less volatile compared to BNGOW. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check BNGOW's competition here
Danaher Corporation (NYSE: DHR-PA)
FLDM vs DHR-PA Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, DHR-PA has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while DHR-PA trades at $1,841.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas DHR-PA's P/E ratio is 233.57. In terms of profitability, FLDM's ROE is +0.18%, compared to DHR-PA's ROE of +0.08%. Regarding short-term risk, FLDM is more volatile compared to DHR-PA. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check DHR-PA's competition here
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
FLDM vs OCDX Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, OCDX has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while OCDX trades at $17.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas OCDX's P/E ratio is -42.28. In terms of profitability, FLDM's ROE is +0.18%, compared to OCDX's ROE of +0.18%. Regarding short-term risk, FLDM is more volatile compared to OCDX. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check OCDX's competition here
Check-Cap Ltd (NASDAQ: CHEKZ)
FLDM vs CHEKZ Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, CHEKZ has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while CHEKZ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas CHEKZ's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to CHEKZ's ROE of +4.17%. Regarding short-term risk, FLDM is less volatile compared to CHEKZ. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check CHEKZ's competition here
ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW)
FLDM vs NDRAW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, NDRAW has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while NDRAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas NDRAW's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to NDRAW's ROE of -2.25%. Regarding short-term risk, FLDM is less volatile compared to NDRAW. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check NDRAW's competition here
PAREXEL Intl Corp. (NASDAQ: PRXL)
FLDM vs PRXL Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, PRXL has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while PRXL trades at $88.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas PRXL's P/E ratio is 42.97. In terms of profitability, FLDM's ROE is +0.18%, compared to PRXL's ROE of +0.17%. Regarding short-term risk, FLDM is more volatile compared to PRXL. This indicates higher risk in terms of short-term price fluctuations for FLDM.Check PRXL's competition here
23andMe Holding Co. (NASDAQ: MEUSW)
FLDM vs MEUSW Comparison October 2026
Standard BioTools Inc. (NASDAQ: FLDM) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FLDM stands at 294.2M. In comparison, MEUSW has a market cap of 0. Regarding current trading prices, FLDM is priced at $3.71 on the NASDAQ, while MEUSW trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FLDM currently has a P/E ratio of -4.74, whereas MEUSW's P/E ratio is N/A. In terms of profitability, FLDM's ROE is +0.18%, compared to MEUSW's ROE of -3.47%. Regarding short-term risk, FLDM is less volatile compared to MEUSW. This indicates lower risk in terms of short-term price fluctuations for FLDM.Check MEUSW's competition here